Article

U.S. expert addresses French medical society

Paris—Yaron S. Rabinowitz, MD, became the third American ophthalmologist to address the Soci?t? Fran?aise d'Ophtalmologie (SFO) annual meeting in the organization's 111-year history when he spoke here May 8 about his keratoconus research.

Paris-Yaron S. Rabinowitz, MD, became the third American ophthalmologist to address the Société Française d'Ophtalmologie (SFO) annual meeting in the organization's 111-year history when he spoke here May 8 about his keratoconus research.

The SFO is the largest ophthalmological society in Europe with about 6,000 members.

Dr. Rabinowitz, who is director of ophthalmology research at Cedars-Sinai Medical Center and clinical professor of ophthalmology at UCLA, was invited as the keynote speaker to share his expertise in the field of cornea and external disease, particularly in the early detection of keratoconus, genetics, and surgery using micro-thin prescription inserts (Intacs, Addition Technology).

The prescription inserts are gaining popularity for vision correction surgery. Addition Technology Inc. announced its first quarter 2005 sales increased by 79% versus the same quarter the prior year, and 44% over fourth quarter 2004.

The European Patent Office also recently issued the company two patents to cover corneal implant technology.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.